LGND - Ligand Pharmaceuticals Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$338.50
DETAILS
HIGH:
$358.00
LOW:
$326.00
MEDIAN:
$336.00
CONSENSUS:
$338.50
UPSIDE:
17.60%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 3,610 | $1.1M | 0.0% | -562 | DECREASED |
| Cooperman | 2,800 | $885,052 | 0.0% | +600 | INCREASED |
| Wood | 800 | $252,872 | 0.0% | +800 | INCREASED |
| Dalio | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 2,074 | $70.04 | $145K |
| 2026-08-12 | Haas Jason | director | M-Exempt | 6,138 | $51.56 | $316K |
| 2026-08-12 | Haas Jason | director | SELL | 7,138 | $292.81 | $2.1M |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 7,171 | $57.22 | $410K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 2,869 | $55.75 | $160K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 16,179 | $52.84 | $855K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | SELL | 31,641 | $292.06 | $9.2M |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 3,348 | $68.74 | $230K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 105 | $284.14 | $30K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 33 | $284.55 | $9K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 157 | $285.74 | $45K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 356 | $288.75 | $103K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 503 | $289.80 | $146K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 200 | $290.60 | $58K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 991 | $291.71 | $289K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 409 | $292.82 | $120K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | M-Exempt | 5,000 | $52.27 | $261K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,032 | $286.80 | $296K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,214 | $287.77 | $349K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 104 | $310.20 | $32K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,119 | $311.72 | $349K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 600 | $317.15 | $190K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | M-Exempt | 5,000 | $52.27 | $261K |
| 2026-06-30 | Espinoza Octavio | officer: Chief Financial Officer | J-Other | 17 | $160.71 | $3K |
| 2026-06-30 | Davis Todd C | director, officer: Chief Executive Officer | J-Other | 132 | $160.71 | $21K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-06-09 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |